Quaker Chemical (KWR) Stock Could Be 11.5% Undervalued After Revenue And Profit Growth

Recent attention on Quaker Chemical (KWR) has been driven by reports of year-over-year growth in revenue and net profit, along with constructive technical indicators that together have drawn fresh interest to the stock.

See our latest analysis for Quaker Chemical.

Beyond the latest results, Quaker Chemical’s share price has been in an upswing, with a 90-day share price return of 23.75% and a 1-year total shareholder return of 33.24%. However, 3 and 5-year total shareholder returns remain negative, suggesting momentum has picked up recently after a tougher multi year period.

If recent strength in Quaker Chemical has you looking for other opportunities, this could be a good moment to broaden your search with 30 best rare earth metal stocks

With Quaker Chemical now trading at $150.24, alongside a recent 23.75% 90 day share price gain and a 13.06% gap to the average analyst price target, you need to ask whether there is still a buying opportunity here or whether the market has already priced in future growth.

Most Popular Narrative: 11.5% Undervalued

With Quaker Chemical last closing at $150.24 against a narrative fair value of about $169.86, the current share price sits below what this widely followed narrative model suggests.

Quaker is seeing double-digit volume growth in its advanced and specialty solutions product line, tied to rising demand for high-performance, sustainable chemistries that support manufacturing automation, energy storage/battery production, and greener industrial processes; this boosts both revenue growth and supports higher margins as product mix shifts favorably.

Read the complete narrative.

Curious how that product mix shift translates into the fair value near $170? The narrative leans heavily on stronger margins, faster earnings growth and a lower future earnings multiple than many investors might expect.

Result: Fair Value of $169.86 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, the Quaker Chemical narrative still depends on margin gains and cost savings coming through as planned, with higher leverage and EMEA weakness serving as potential pressure points.

Find out about the key risks to this Quaker Chemical narrative.

Another View: Quaker Chemical Looks Expensive on Sales

While the narrative fair value suggests Quaker Chemical is 11.5% undervalued around $169.86, the current $150.24 share price already reflects a P/S ratio of 1.4x. That is richer than the US Chemicals industry average of 1.1x, even if it sits in line with peers and slightly below a 1.6x fair ratio.

This mix of an implied discount on the narrative model and a premium to the wider industry on sales leaves you weighing which signal matters more for your own risk tolerance and time horizon.

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Does the mix of recent strength and past setbacks at Quaker Chemical leave you optimistic or cautious? If you want to move quickly and build your own view, weigh the upside and downside by checking the 1 key reward and 3 important warning signs.

Looking for more investment ideas beyond Quaker Chemical?

If Quaker Chemical has sharpened your interest in what else could be worth your time, do not stop here, widen your search and stay ahead of the crowd.

• Spot potential mispricing by scanning 44 high quality undervalued stocks that combine resilient cash flows with balance sheets many investors might be overlooking.
• Prioritise staying power by checking out 66 resilient stocks with low risk scores that score well on stability so short term swings are less likely to dominate the story.
• Get ahead of the herd by reviewing a screener containing 19 high quality undiscovered gems before broader market attention catches up.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com